Dr Darren McGuire from UT Southwestern Medical Center in Dallas, Texas, has expertise in clinical trial design and execution of large-scale cardiovascular outcomes studies, with a focus in the area of diabetes and cardiovascular disease. This places him at the forefront of an emerging treatment paradigm in cardiology where specific antihyperglycaemic agents are used for ...
Dr Darren McGuire on why cardiologists should consider specific antihyperglycaemic agents for CV risk mitigation
13 Aug 2019
Sponsored by Boehringer Ingelheim Pty Ltd